The Best of Canadian Science and Technology
Mackie Research analyst André Uddin reviewed the state of affairs for drug developer Bellus Health (Bellus Health Stock Quote, Chart, News TSX:BLU) in … [Read more...] about Bellus Health keeps “Hold” rating at Mackie Research Capital
Medical imaging company Akumin (Akumin Stock Quote, Chart, News TSX:AKU.U) is now dual listed on both the TSX and NASDAQ, a move that should help … [Read more...] about Buy medical imaging stock Akumin for a double, Clarus says
Stifel GMP analyst Justin Keywood likes the look of the new deal from WELL Health Technologies (WELL Health Technologies Stock Quote, Chart, News … [Read more...] about WELL Health gets bullish new $7.00 target at Stifel
Healthcare name ImmunoPrecise Antibodies (ImmunoPrecise Antibodies Stock Quote, Chart, News TSXV:IPA) is now gaining traction, says Industrial … [Read more...] about ImmunoPrecise Antibodies gets price target raise from Industrial Alliance
Industrial Alliance Securities analyst Chelsea Stellick launched coverage of Appili Therapeutics (Appili Therapeutics Stock Quote, Chart, News … [Read more...] about Appili Therapeutics gets new “Buy” rating at Industrial Alliance
After closing on a Colorado acquisition, Beacon Securities analyst Russell Stanley is bumping up his target price on Columbia Care (Columbia Care … [Read more...] about Beacon Securities raises target on Columbia Care to $7.00
Another record quarter from Protech Home Medical (Protech Home Medical Stock Quote, Chart, News TSXV:PTQ) has M Partners analyst Paul Piotrowski … [Read more...] about We’re still bullish on Protech Home Medical, M Partners says
The news is bad for Acasti Pharma (Acasti Pharma Stock Quote, Chart, News TSX:ACST), according to Echelon Wealth analyst Douglas Loe, who on Monday … [Read more...] about Sell Acasti Pharma, says Echelon Wealth
Calling Theralase Technologies (Theralase Technologies Stock Quote, Chart, News TSXV:TLT) a high-risk, high-reward investment opportunity, Mackie … [Read more...] about Theralase is a high risk/high reward play, says Mackie Research
There’s likely more upside to come from Neptune Wellness Solutions (Neptune Wellness Solutions Stock Quote, Chart, News TSX:NEPT) after a new deal … [Read more...] about Unilever deal is good for Neptune Wellness, says Echelon
